LabCritics

@LabSpend Hey guys.. Trying to connect.. Reply to open DMs?

Is your lab's inventory living in a spreadsheet nobody trusts? Bring it current with simply taking image of your item labels!! Lean more about our FREE inventory solution: labspend.com #LabManagement #Biotech #ResearchOperations #LabOps

The one-person pharma company doesn't fully exist yet. But the unit of drug creation is shrinking — from thousands of people, to a small team, to an individual with a laptop, a cloud lab, and an army of AI agents. Full piece -> labcritics.com/blog/2026/07/0… #AIxBio

Asia's rare-disease burden is huge — and ignored by big pharma. n-of-1 medicine is built for exactly those patients. Building AI fluency across the region's research institutes is how a Silicon Valley thought experiment becomes real medicine.

The Rise of the One-Person Pharma Company Sam Altman thinks the first one-person, billion-dollar company is coming. What almost no one is saying: it might not be a software app. It might be a drug. Here's why the "one-person pharma company" is closer than you think ↓

@Junioryu136689 @btnaughton How have you stayed off our radar for so long??

@btnaughton Thanks for the shoutout! Really appreciate it 🙌

Following a trail of breadcrumbs from a Chinese AIxBio website biotender.online to "One-Person AI Pharma" and then to OpenDDE from Aureka Bio (in California!?). No real twitter presence, all very under the radar somehow... biotender.online/one-person-pha… github.com/aurekaresearch…

Full breakdown — all 3 launches, the Boltz-1→2→Gen lineage, and head-to-head vs AlphaFold3, Chai-2 & the Baker-lab stack: 🔗 labcritics.com/blog/2026/06/1… #AIdrugdiscovery #ProteinDesign #TechBio #DeSci

Every result here is vendor-reported on Boltz's own targets. There's still no shared, blinded benchmark for de novo hit rates. The technical reports are where the scrutiny should go. Strong claims, aggressive distribution. Real world usage will give us the full picture..

Boltz just went full-stack. 🧬The MIT-born co-folding lab dropped THREE things at once: BoltzMol-1, BoltzProt-1, and the Boltz API.Translation: they went from "we predict structures" → "we find your molecules."